Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ETON · against 1,336 other Healthcare companies
Ranked #810 of 1,337 · scores higher than 39% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 30–39, including ETON · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | ETON | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 0.8% | 1.5% | 45% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 1.7% | 4.2% | 38% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -0.0% | -1.0% | 54% | 20% | |
| Book yieldHigher is better · 1,306 reported | 3.2% | 37.9% | 8% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 810 | 2.2B CNY (≈$310M) | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 39 |
| 810 | 62.7B JPY (≈$426M) | 39 | 40 |
| 810 | 27.6B SEK (≈$2.8B) | 39 | 76 |
| 810 | 2.67T INR (≈$32.1B) | 39 | 68 |
| 810 | 1.5B USD | 39 | 63 |
| 810 | 79M EUR (≈$87M) | 39 | 25 |
| 810 | 9.4B USD | 39 | 70 |
| 810 | 2.6B USD | 39 | 32 |
| 810 | 354M USD | 39 | 41 |